AMA Endorses ASCP’s Call for a National Testing Strategy

On April 27, the American Medical Association (AMA) urged the Trump Administration to develop a National Strategy much like ASCP’s recent recommendation. In a letter to U.S. Health and Human Services Assistant Secretary Admiral Brett Giroir, MD, the AMA called for a national strategy that encourages the federal government to exert stronger leadership to help clinical laboratories acquire testing components that are in short supply. Many of the themes touched upon in the AMA letter parallel ASCP’s recommendations, such as providing “greater clarity and transparency around existing testing capacity,” increasing communication between the federal government, states and laboratories; ensuring clinical laboratories are adequately resourced; and providing appropriate review and guidance on the use of serological testing. ASCP has been working with the AMA's White House staff and is pleased to see the AMA's call for increased federal coordination.

Other articles in the May 2020 ePolicy News:

• New Law Includes Funding for COVID-19 Testing, ASCP Recommendations for Testing Strategy
• ASCP Urges Creation of National COVID-19 Testing Task Force
• Governors, State Health Directors Hear from ASCP BOC about COVID-19 Response
• ASCP, FDA Share Similar Concerns on Antigen Testing
• Hazard Pay, Mental Health Benefits Sought for Pathologists, Laboratory Professionals
• ASCP Interviewed about Job Satisfaction, Well-Being of Pathologists
• CMS Urged to Consider Specialists When Implementing MIPS Value Pathways
• Updated Risk-Based Guidelines Now Published for Management of Abnormal Results in Cervical Cancer Screening and Colposcopy

To read more articles from ePolicy News click here.

For more information regarding ASCP's advocacy initiatives and policy positions, please contact ASCP's Center for Public Policy at (202) 408-1110.

 ASCP ePolicy News is supported by an unrestricted grant from Hologic.